|
|
||||||||
The Journal of Immunology, Vol 154, Issue 6 2775-2783, Copyright © 1995 by American Association of Immunologists
ARTICLES |
PA Sieling, L Sakimura, K Uyemura, M Yamamura, J Oliveros, BJ Nickoloff, TH Rea and RL Modlin
Division of Dermatology, University of California, Los Angeles, School of Medicine, CA 90095.
The goal of the present study was to investigate the role of IL-7 in regulating immune responses to infection. Leprosy provides a model for understanding human immune responses to infection; the disease presents as a spectrum in which the clinical manifestations correlate with the levels of cell-mediated immunity to the pathogen, Mycobacterium leprae. To determine whether IL-7 is produced at the site of infection in leprosy, we used the PCR to measure IL-7 and IL-7R mRNA in skin lesions. IL-7 mRNA was more strongly expressed in the tuberculoid form of the disease, in which the infection is limited (mean cpm = 48 +/- 8; n = 11), as compared with the progressive lepromatous form (17 +/- 2; n = 11). IL-7R mRNA, both membrane-bound and soluble forms, were also more strongly expressed in tuberculoid lesions, although these differences were not as striking as those for IL-7. The cellular source of IL-7 included Ag-stimulated monocytes and IFN-gamma-induced keratinocytes. M. leprae-induced PBMC responses in tuberculoid patients involved up-regulation of IL-7 and IL-7R mRNA and was IL-7 dependent. In contrast, M. leprae did not induce IL-7 mRNA in lepromatous patients, and their T cell responses were weakly augmented by rIL-7. These data suggest that IL-7, produced at the site of disease, contributes to the cell-mediated immune response to human pathogens.
This article has been cited by other articles:
![]() |
S A Y Hartgring, J W J Bijlsma, F P J G Lafeber, and J A G van Roon Interleukin-7 induced immunopathology in arthritis Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii69 - iii74. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gilbertson, S. Germano, P. Steele, S. Turner, B. F. de St. Groth, and C. Cheers Bystander Activation of CD8+ T Lymphocytes during Experimental Mycobacterial Infection Infect. Immun., December 1, 2004; 72(12): 6884 - 6891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bleharski, H. Li, C. Meinken, T. G. Graeber, M.-T. Ochoa, M. Yamamura, A. Burdick, E. N. Sarno, M. Wagner, M. Rollinghoff, et al. Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease Science, September 12, 2003; 301(5639): 1527 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maeurer, P. Trinder, G. Hommel, W. Walter, K. Freitag, D. Atkins, and S. Storkel Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice Infect. Immun., May 1, 2000; 68(5): 2962 - 2970. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hameg, C. Gouarin, J.-M. Gombert, S. Hong, L. Van Kaer, J.-F. Bach, and A. Herbelin IL-7 Up-Regulates IL-4 Production by Splenic NK1.1+ and NK1.1- MHC Class I-Like/CD1-Dependent CD4+ T Cells J. Immunol., June 15, 1999; 162(12): 7067 - 7074. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Roye, N. Delhem, F. Trottein, F. Remoue, S. Nutten, J.-P. Decavel, M. Delacre, V. Martinot, J.-Y. Cesbron, C. Auriault, et al. Dermal Endothelial Cells and Keratinocytes Produce IL-7 In Vivo After Human Schistosoma mansoni Percutaneous Infection J. Immunol., October 15, 1998; 161(8): 4161 - 4168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |